Insider Sale: 10% owner at $LTRN Sells 21,557 Shares

Aaron G.L. Fletcher, a 10% owner of $LTRN, sold 21,557 shares on 06-12-2025 for approximately $72,862, representing 5.3% of their holdings; Fletcher and Leslie W. Kreis have each made 30 sales in the last six months. Recent institutional activity in $LTRN shows mixed sentiment, with VOSS CAPITAL, LP increasing its position by 50,000 shares in Q4 2024, while CITADEL ADVISORS LLC, REDMOND ASSET MANAGEMENT, LLC, TOCQUEVILLE ASSET MANAGEMENT L.P., and TWO SIGMA INVESTMENTS, LP eliminated their positions in Q1 2025 and Q4 2024.

Analysis

Persistent insider selling at Lantern Pharma Inc. ($LTRN) warrants significant attention, highlighted by a recent sale from 10% owner Aaron G.L. Fletcher, who divested 21,557 shares for approximately $72,862 on June 12, 2025, reducing his holdings by 5.3%. This transaction is part of a broader trend over the past six months where $LTRN insiders executed 60 sales and zero purchases; notably, Fletcher and Leslie W. Kreis each sold 117,850 shares, realizing an estimated $376,690 apiece. This consistent selling pressure contributes to a strongly negative sentiment score of -0.7 for the stock. Institutional activity presents a more nuanced, yet concerning, view: while 14 firms added shares and 13 reduced them in the most recent quarter, several significant investors including CITADEL ADVISORS LLC, REDMOND ASSET MANAGEMENT, LLC, and TWO SIGMA INVESTMENTS, LP completely liquidated their positions in Q1 2025, alongside TOCQUEVILLE ASSET MANAGEMENT L.P. in Q4 2024. Although VOSS CAPITAL, LP initiated a 50,000 share position in Q4 2024 and PERIGON WEALTH MANAGEMENT, LLC added 24,787 shares in Q1 2025, the substantial insider divestment and exits by notable funds suggest a cautious outlook is warranted.

Key Decisions for Investors

• Investors should exercise heightened caution regarding $LTRN due to the pronounced and consistent insider selling activity, including by a major shareholder, which often signals internal concerns about valuation or future prospects.
• Carefully evaluate the mixed institutional signals, particularly the complete divestment by prominent funds like Citadel Advisors and Two Sigma Investments, which may outweigh the new positions taken by smaller or different types of investors.
• Closely monitor future insider transaction filings and institutional holdings reports for any deceleration in selling pressure or a more unified positive shift in institutional sentiment before considering new or increased exposure to $LTRN.